Global Microbiome Sequencing Services Market Report and Forecast 2024-2032

Global Microbiome Sequencing Services Market Outlook

The global microbiome sequencing services market size was valued at USD 2.17 billion in 2023, driven by the rising number of dental caries among all age groups across the globe. The market size is anticipated to grow at a CAGR of 20.6% during the forecast period of 2024-2032 to achieve a value of USD 11.72 billion by 2032.

Microbiome Sequencing Services: Introduction

Microbiome sequencing is a method of decoding the genetic material of all the microorganisms in a sample including bacteria, virus, fungi, and protists. There are two major methods that are used, one is whole genome shotgun sequencing (WGS), and the other one is amplicon sequencing. WGS is an unbiased method that detects all the genetic material in the sample. Amplicon sequencing targets a portion of the genetic material that is shared among the microorganisms but contains regions of variability that allow their identification. Identification of microorganisms in a sample by sequencing techniques and data analysis allows several advantages over traditional culturing approaches.

Global Microbiome Sequencing Services Market Analysis

The increasing demand for personalized supplements or treatments among the patients is directly influencing the market growth. The pharmaceutical companies are investing heavily in the development of more customer centric medications, such as personalized medications and supplements. For example, DSM Venturing has invested in a crop of startup Sun Genomics, which is taking advantage of the growing precision of microbiome research. The approach is expected to combine whole-genome sequencing with gut composition analysis to produce personalized supplements for each customer. The continuously ongoing explorations, heavy investments, developments of new innovative products are strongly anticipated to boost the global microbiome sequencing services market demand.

The increasing research and development activities to explore the potential of microbiome sequencing in body parts other than the gut has also been creating traction. There are several companies that have already begun to develop products targeting them. The increasing utilization of microbiome sequencing services towards skin is being used as basis for cosmetics.

Global Microbiome Sequencing Services Market Segmentations

Market Breakup by Products and Services

• Reagents and Consumables

• Instruments

• Services

Market Breakup by Technology

• Sequencing by Synthesis

• Sequencing by Ligation

• Shotgun Sequencing

• Sanger Sequencing

• Pyrosequencing

• Other Technologies

Market Breakup by Applications

• Drug Development

• Agriculture and Food Industry

• Environmental Monitoring

• Others

Market Breakup by End Use

• Academic and Research Institutes

• Pharmaceutical and Biotechnology Companies

• Contract Research Organizations (CROs)

• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Microbiome Sequencing Services Market Overview

The rising number of research and development activities and clinical trials due to the increasing awareness about the potential of microbiome associated with health and diseases is a major factor driving the market growth.

As result of various studies, microbiome has been proven to have the ability to be used in the production of personalized medicines, which works by targeting the issue. This ability of microbiome to be used to produce personalized medicine for better patient outcomes, there has been a surge in the demand for personalized medicine in the market. The increasing demand and awareness about personalized medicines is further propelling the global microbiome sequencing services market growth.

The rising prevalence of chronic diseases, such as obesity, diabetes, and inflammatory bowel disorders, is a major factor responsible for the increased since these medical conditions may require personalized medicines for the patients depending upon their genetic arrangements.

There has been an interest developing recently towards exploring the potential of microbiome sequencing services in learning more about the connections between the gut and the brain health which is further expected to aid the global microbiome sequencing services market share. The expansion of microbiome sequencing services fields other than pharmaceuticals such as cosmetics are also expected to support the market expansion.

Microbiome Sequencing Services Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Illumina, Inc.

• Thermo Fisher Scientific, Inc.

• Pacific Biosciences of California, Inc.

• Oxford Nanopore Technologies Ltd.

• Qiagen N.V.

• BaseClear B.V.

• Zymo Research Corporation

• Second Genome

• Microbiome Insights Inc.

• CosmosID Inc.

Key Highlights of the Report